SCHEMBL4722351

SCHEMBL4722351

CC(C)C/C=C(/C=O)c1ccccc1.CC(C=O)Cc1ccc(C(C)C)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
TP53 P04637 1/20 0.40
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
PTGS1 P23219 3/20 0.35
PTGS2 P35354 3/20 0.35
LMNA P02545 2/20 0.35
CYP2C9 P11712 2/20 0.35
AKR1C3 P42330 2/20 0.35
CXCR1 P25024 2/20 0.35
CXCR2 P25025 2/20 0.35
ALOX5 P09917 2/20 0.35
ALB P02768 1/20 0.35
ESR1 P03372 1/20 0.35
RARB P10826 1/20 0.35
ADRB3 P13945 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4722353 1.00 TSHR (0.40) TSHRNPC1RAB9ATP53KDM4E
SCHEMBL891499 0.81 ALDH1A1 (0.41) TSHRKDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL891343 0.81 ALDH1A1 (0.41) TSHRKDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL2432464 0.81 ALDH1A1 (0.41) TSHRKDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL1148 0.77 TSHR (0.61) TSHRTP53MEN1KMT2APTGS1
SCHEMBL29487262 0.77 TSHR (0.61) TSHRTP53MEN1KMT2APTGS1
P-Cymene SCHEMBL23296191 0.71 TP53 (0.54) TSHRTP53PTGS1PTGS2LMNA
SCHEMBL3484487 0.70 TP53 (0.60) TSHRNPC1RAB9ATP53MEN1
SCHEMBL97559 0.70 TP53 (0.60) TSHRNPC1RAB9ATP53MEN1
SCHEMBL286217 0.70 TP53 (0.60) TSHRNPC1RAB9ATP53MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080247966-A1 Compositions and Methods to Counteract Oral Malodour GIVAUDAN SA (CH) 2008-10-09 US disclosed
EP-1919566-A1 COMPOSITIONS AND METHODS TO COUNTERACT ORAL MALODOUR Givaudan SA (CH) 2008-05-14 EP disclosed
WO-2007025401-A1 COMPOSITIONS AND METHODS TO COUNTERACT ORAL MALODOUR GIVAUDAN SA (CH) 2007-03-08 WO disclosed